on Gimv (EBR:GIMB)
Gimv Shifts Focus, Ends New Life Sciences Investments
Gimv, the European investment company, will discontinue its new investments in Life Sciences to focus on strategic objectives. This decision aligns with Gimv's ambitions for growth. The firm will prioritize its investment platforms: Consumer, Healthcare, Smart Industries, and Sustainable Cities. Gimv sees these areas offering significant growth opportunities amidst the digital transition.
The existing Life Sciences portfolio, comprising 11 companies and representing about 5% of Gimv's total portfolio value, will remain. Value maximization will be sought in consultation with the current companies and syndicate investors. Gimv's executive committee will review its composition accordingly, with potential changes to the Life Sciences team.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Gimv news